BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 436362)

  • 1. Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.
    Brunswick DJ; Amsterdam JD; Mendels J; Stern SL
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):605-10. PubMed ID: 436362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting imipramine dose in children with depression.
    Sallee F; Stiller R; Perel J; Rancurello M
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of serum levels of imipramine and desipramine and individualization of dose in enuretic children.
    de Gatta MF; García MJ; Acosta A; Rey F; Gutierrez JR; Dominguez-Gil A
    Ther Drug Monit; 1984; 6(4):438-43. PubMed ID: 6515703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
    Szymura-Oleksiak J; Wasieczko A
    Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time.
    Ziegler VE; Biggs JT; Rosen SH; Meyer DA; Preskorn SH
    J Clin Psychiatry; 1978 Aug; 39(8):660-3. PubMed ID: 681303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder.
    Mavissakalian MR; Perel JM
    Psychopharmacol Bull; 1996; 32(1):143-7. PubMed ID: 8927664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
    Spina E; Arena A; Pisani F
    Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronopharmacokinetics of imipramine and desipramine in rat forebrain and plasma after single and chronic treatment with imipramine.
    Lemmer B; Holle L
    Chronobiol Int; 1991; 8(3):176-85. PubMed ID: 1794155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose kinetics predict steady-state concentrations on imipramine and desipramine.
    Potter WZ; Zavadil AP; Kopin IJ; Goodwin FK
    Arch Gen Psychiatry; 1980 Mar; 37(3):314-20. PubMed ID: 7362419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of imipramine after single and multiple intravenous administration in rats.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1983; 35(2):151-7. PubMed ID: 6622297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: a preliminary report.
    Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Shea C; Tabrizi MA; Stiller RL
    J Am Acad Child Psychiatry; 1979; 18(4):616-27. PubMed ID: 541469
    [No Abstract]   [Full Text] [Related]  

  • 12. Imipramine blood levels and clinical outcome.
    Rigal JG; Albin HC; Duchier AR; D'Aulnay JM; Fenelon JH; Vincon GA; Demotes-Mainard FM
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.
    Daniel W; Adamus A; Melzacka M; Szymura J; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):209-13. PubMed ID: 7322212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for the kinetics of imipramine and its metabolites in adolescents.
    Dell RB; Hein K; Ramakrishnan R; Puig-Antich J; Cooper T
    Ther Drug Monit; 1990 Sep; 12(5):450-9. PubMed ID: 2293407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A; Johansson R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):145-60. PubMed ID: 1102994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Variations in the blood levels of imipramine and desmethylimipramine, depending upon the route of administration, intramuscular or oral, of Tofranil].
    Rigal J; Albin H; França X; Vinçon G; Démotes-Mainard F
    Ann Med Psychol (Paris); 1988; 146(8):764-72. PubMed ID: 3242402
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine.
    DeVane CL; Jusko WJ
    Drug Intell Clin Pharm; 1981 Apr; 15(4):263-6. PubMed ID: 7274042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of imipramine in children.
    Tamayo M; Fernández de Gatta MM; García MJ; Domínguez-Gil A
    Eur J Clin Pharmacol; 1992; 43(1):89-92. PubMed ID: 1505617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma levels of imipramine and desmethylimipramine and antidepressant effect during controlled therapy(author's transl)].
    Oliver-Marti n R; Buschsenschultz E; Pichot P; Boissier J
    Psychopharmacologia; 1975; 41(2):187-95. PubMed ID: 1153607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.